NCT00463242 · Interventional trial
A Placebo- and Paroxetine-controlled Study of the Efficacy, Safety and Tolerability of Agomelatine (25 or 50 mg) in the Treatment of Major Depressive Disorder (MDD)
Overall registry status Completed
Phase 3
Conditions Major Depressive Disorder
Delaware Valley sites
- Novartis Investigative Site · Media, PA · Delaware County
- Novartis Investigative Site · Philadelphia, PA · Philadelphia County
- Novartis Investigative Site · Willingboro, NJ · Burlington County
First posted
Registry updated
Added to the directory